Full Text View
Tabular View
No Study Results Posted
Related Studies
Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity
This study has been completed.
Study NCT01456845   Information provided by All India Institute of Medical Sciences, New Delhi

First Received on October 20, 2011.   Last Updated on August 30, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatitis
Tuberculosis
Additional conditions recognized in this trial
Hepatitis A
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Digestive System Diseases
Enterovirus Infections
Gram-Positive Bacterial Infections
Hepatitis, Viral, Human
Liver Diseases
Mycobacterium Infections
Picornaviridae Infections
RNA Virus Infections
Virus Diseases
Additional drug interventions recognized in this trial
Antitubercular Agents
Isoniazid
Pyrazinamide
Rifampin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Antimetabolites
Enzyme Inhibitors
Fatty Acid Synthesis Inhibitors
Hypolipidemic Agents
Leprostatic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
All India Institute of Medical Sciences, New Delhi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services